Guest editorial: The use of actigraphy for objective detection of sleep impairments in substance use disorders
- 3 June 2026
- journal article
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 88, 102319
Abstract
No abstract availableFunding Information
- National Institutes of Health (DA049886)
- National Institutes of Health (DA058666)
This publication has 21 references indexed in Scilit:
- Sleep alterations in substance use disorders: a systematic review and meta-analysiseClinicalMedicine, 2026
- Effects of methamphetamine-induced sleep disruption on intradimensional/extradimensional attentional set-shifting in adult rhesus monkeysThe Journal of Pharmacology and Experimental Therapeutics, 2025
- Effects of methamphetamine on actigraphy-based sleep parameters in female rhesus monkeys: Orexin receptor mechanismsDrug and Alcohol Dependence, 2024
- Sleep features in alcohol use disorder: A systematic review and meta-analysis of polysomnographic findings in case-control studiesThe European Journal of Psychiatry, 2023
- Effects of methadone, buprenorphine, and naltrexone on actigraphy-based sleep-like parameters in male rhesus monkeysAddictive Behaviors, 2022
- The dual orexin receptor antagonist almorexant blocks the sleep-disrupting and daytime stimulant effects of methamphetamine in rhesus monkeysDrug and Alcohol Dependence, 2021
- Clinician-Focused Overview and Developments in PolysomnographyCurrent Sleep Medicine Reports, 2020
- Agreement between actigraphic and polysomnographic measures of sleep in adults with and without chronic conditions: A systematic review and meta-analysisSleep Medicine Reviews, 2019
- Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugsAddictive Behaviors, 2017
- Nicotine dependence and sleep quality in young adultsAddictive Behaviors, 2017